VitaDAO is a decentralized autonomous organizations (DAO) collective for community-governed and decentralized drug development. It aims to acquire, support, and finance new therapeutics and research data in the longevity space.
The public can join VitaDAO and govern its IP through VITA-FAST tokens by contributing funds, work, research data, or IP assets. VITA-FAST tokens enable their holder to engage in decision-making and governance of VitaDAO’s research, signal support for specific initiatives, and govern its data repositories and IP portfolio.
Key customers and partnerships
As of June 2023, VitaDAO had a community of over 9,000 researchers and contributors, and had distributed more than USD 4 million in funding to over 17 longevity-based research projects.
Funding and financials
It raised USD 4.1 million in a strategic funding round in January 2023, which saw participation from Pfizer Ventures, Shine Capital, and L1 Digital among others. The fresh funds were geared towards investing in longevity research projects, precede the spinout of VitaDAO’s first biotech startups scheduled in Q1 2023, and commercialize and license its IP-NFT assets through its partnership with Molecule DAO .
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.